Epigenomics Licenses Protein Biomarker Technology for Blood-

EQS-News: Epigenomics AG


/ Key word: Alliance/Miscellaneous





Epigenomics Licenses Protein Biomarker Technology for Blood-based Colorectal Cancer Test






14.12.2022 / 05:16... | December 14, 2022

Related Keywords

Germany , San Diego , California , United States , Berlin , Greg Hamilton , Anderson Cancer Center , University Of Texas , Drug Administration , Epigenomics Inc , Epigenomics Licenses Protein Biomarker Technology , Blood Based Colorectal Cancer , United Statesa , Frankfurt Prime Standard , Frederic Hilke , Epigenomics Ag Stock Exchange , News , Information , Press Release , Epigenomics , Key , Licenses , Protein , Biomarker , Technology , Or , Olorectal , Dancer , Est Ecx De000a11qw50 ,